Certified by Founder Lodge
Amplitude Ventures
Canada - Montreal, Quebec
INVESTOR
1 Disclosed Funding Rounds $65,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Amplitude Ventures is a capital catalyst for highly innovative companies at the point of value acceleration. We work with Canada's most promising healthcare companies that share our vision of
| Company | Date | Round | Raised |
|---|---|---|---|
 Congruence Therapeutics |
March, 07 ,2023 | Series A | $65,000,000 |
 Gandeeva Therapeutics |
January, 31 ,2022 | Series A | $40,000,000 |
 Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 Evommune |
April, 27 ,2023 | Series B | $50,000,000 |
 Ability Biologics |
December, 07 ,2023 | Seed | $12,000,000 |
 Nomic Bio |
September, 18 ,2024 | Series B | $42,000,000 |
 Fluid Biomed Inc. |
December, 18 ,2024 | Series A | $27,000,000 |
 Reverb Therapeutics |
February, 21 ,2025 | Seed | $21,000,000 |
 Cambio |
January, 23 ,2026 | Series A | $18,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Manufact (formerly mcp-use) | $6,300,000 | (Feb 13, 2026)
CYDELPHI | $3,000,000 | (Feb 13, 2026)
Integrate | $17,000,000 | (Feb 13, 2026)
Maestro Tech, Inc. | $1,200,000 | (Feb 13, 2026)
Reflow | $15,000,000 | (Feb 13, 2026)
